Clinical

Dataset Information

0

Evaluation of the diagnostic quality of manganese chloride tetrahydrate (CMC-001©) in liver magnetic resonance imaging in patients with liver metastases in comparison to gadolinium benzyloxypropionictetraacetate (BOPTA): a randomised cross-over phase III trial


ABSTRACT: Study hypothesis: The primary objective is to assess the feasibility of manganese chloride tetrahydrate (CMC-001©) as a contrast medium in liver Magnetic Resonance Imaging (MRI) scanning in patients with liver metastases in comparison with gadolinium Benzyloxypropionictetraacetate (BOPTA) (MultiHance©) MRI. Primary outcome(s): The primary objective is to assess the feasibility of CMC-001© as a contrast medium in liver MRI scanning in patients with liver metastases in comparison with gadolinium BOPTA (MultiHance©) MRI.

DISEASE(S): Colorectal Cancer

PROVIDER: 2425454 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJNA1085472 | ENA
| 2205988 | ecrin-mdr-crc
| 2456821 | ecrin-mdr-crc
2022-10-19 | GSE216069 | GEO
2022-10-19 | GSE216055 | GEO
| 2061960 | ecrin-mdr-crc
| PRJNA153395 | ENA
| 2717641 | ecrin-mdr-crc
2022-01-17 | GSE193171 | GEO
| 2620536 | ecrin-mdr-crc